|
|
|
| Why Precise Personal Management is Needed in Glaucoma |
| Jian Ge |
Zhongshan Ophthalmic Center, SunYat-sen University, State Key Laboratory of Ophthalmology,
Guangzhou 510060, China |
|
|
|
|
Abstract Glaucoma is a type of nerve blinding eye disease that is irreversible. The features of the disease and our cognitive limitations make it impossible to fully prevent development and progression. Even though many great innovations in basic science and clinical practice have been made, the clinical management and blindness rate of glaucoma have not been improved. Therefore, it is necessary that new clinical strategies be adapted that focus precisely on the management of individual glaucoma cases.
|
|
Received: 08 May 2017
|
|
|
|
| [1] |
Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA, 2014, 311(18): 1901-1911. DOI: 10.1001/jama. 2014.3192.
|
| [2] |
Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol, 2006, 90(3): 262-267. DOI: 10.1136/bjo.2005.081224.
|
| [3] |
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship betweencontrolofintraocularpressureandvisualfielddeterioration. The AGIS Investigators. Am J Ophthalmol, 2000, 130(4): 429-440.
|
| [4] |
Gordon MO, Kass MA. The OcularHypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol, 1999, 117(5): 573-583.
|
| [5] |
中华医学会眼科学分会青光眼学组. 我国原发性青光眼诊断和治疗专家共识（2014年）. 中华眼科杂志, 2014, 50(5): 382-383. DOI: 10.3760/cma.j.issn.0412-4081.2014.05.022.
|
| [6] |
Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost foropen-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet, 2015, 385(9975): 1295- 1304.DOI: 10.1016/S0140-6736(14)62111-5.
|
| [7] |
KrupinT,LiebmannJM,GreenfieldDS,etal. TheLow-pressure
|
|
Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients. Ophthalmology, 2005, 112(3): 376-385. DOI: 10.1016/j.ophtha.2004.10.034.
|
| [8] |
葛坚, 郭彦, 刘奕志, 等. 超声乳化白内障吸除术治疗闭角型青光眼的初步临床观察. 中华眼科杂志, 2001, 37(5): 355 -358. DOI:10.3760/j:issn:0412-4081.2001.05.010.
|
| [9] |
中华医学会眼科学分会青光眼学组, 中华医学会中华眼科杂志编辑委员会. 我国原发性青光眼诊断和治疗专家共识. 中华眼科杂志, 2008, 44(9): 862 -863. DOI: 10.3321/j.issn:0412-4081.2008.
|
| [10] |
Azuara-Blanco A, Burr J, Ramsay C, et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet, 2016, 388(10052): 1389-1397. DOI: 10.1016/S0140-6736(16) 30956-4.
|
| [11] |
Savatovsky E, Mwanza JC, Budenz DL, et al. Longitudinal changes in peripapillary atrophy in the ocular hypertension treatment study: a case-control assessment. Ophthalmology, 2015, 122(1): 79-86. DOI: 10.1016/j.ophtha.2014.07.033.
|
| [12] |
Bhorade AM, Gordon MO, Wilson B, et al. Variability of intraocular pressure measurements in observation participants in the ocular hypertension treatment study. Ophthalmology, 2009, 116(4): 717-724. DOI: 10.1016/j.ophtha.2008.12.036.
|
| [13] |
Feuer WJ, Parrish RK, Schiffman JC, et al. The Ocular Hyper tension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center. Am J Ophthalmol, 2002, 133(1): 19-28.
|
| [14] |
De Moraes CG, Demirel S, Gardiner SK, et al. Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group. Invest Ophthalmol Vis Sci, 2012, 53(4): 1704-1709. DOI: 10.1167/iovs.11-8186.
|
| [15] |
葛坚. 青光眼视神经损伤与修复期精准的个体化治疗. 中华实验眼科杂志, 2017, 35(4): 289 -292. DOI: 10.3760/cma.j.issn. 2095-0160.2017.04.001.
|
|
|
|
